-
Signature
-
/s/ Rogan Nunn, by power of attorney
-
Issuer symbol
-
OKUR
-
Transactions as of
-
01 Apr 2026
-
Net transactions value
-
$0
-
Form type
-
4
-
Filing time
-
03 Apr 2026, 15:29:11 UTC
Quoteable Key Fact
"Nicholas A. Saccomano filed Form 4 for OnKure Therapeutics, Inc. (OKUR) on 03 Apr 2026."
Quick Takeaways
- This page summarizes Nicholas A. Saccomano's Form 4 filing for OnKure Therapeutics, Inc. (OKUR).
- 1 reported transaction and 1 derivative row are listed below.
- Filing timestamp: 03 Apr 2026, 15:29.
What Changed
- Previous filing in this sequence was filed on 24 Mar 2026.
- Current net transaction value: $0.
Why This Matters
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Saccomano Nicholas A |
President and CEO, Director |
C/O ONKURE THERAPEUTICS, INC., 6707 WINCHESTER CIRCLE, SUITE 400, BOULDER |
/s/ Rogan Nunn, by power of attorney |
03 Apr 2026 |
0001609284 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
OKUR |
Employee Stock Option (right to buy) |
Award |
|
+330,000 |
|
$0.000000* |
330,000 |
01 Apr 2026 |
Class A Common Stock |
330,000 |
$4.07 |
Direct |
F1 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Explanation of Responses: